hava klemperer meretzki  vice chairmannational council at israel bar association news home advertising board and executive moves energy health care hedge funds m  a private equity technology you have    free profiles   left this month    start your free trial ➤ hey we noticed youre a relsci pro subscriber would you like to view the page there view on relsci pro ➤ email linkedin facebook google tweet reddit permalink hava klemperer meretzki vice chairmannational council at israel bar association overview relationships paths education career history boards  committees public holdings awards  honors hava klemperer meretzki vice chairmannational council at israel bar association overview age  born  awards  board seats  number of relationships this person is connected to  people relationships see details zami aberman chairman  cochief executive officer at pluristem therapeutics inc yaky yanay director president  cochief executive officer at pluristem therapeutics inc doron shorrer chairman  chief executive officer at shorrer international ltd meir linzen senior managing partner at herzog fox neeman moria kwiat research fellow department of material  nanosciences at tel aviv university  school of chemistry israel ben yoram chief executive officer at zonbit ltd isaac braun member board of directors at pluristem therapeutics inc mark germain managing director at the olmsted group nachum rosman chief executive officer at simba ltd adi goldin associate at israel bar association see  more listings with relsci professional start my free trial ➤ see  more paths to hava klemperer meretzki hava klemperer meretzki you connections via relationship science hava klemperer meretzki sync your contacts to see how you can connect with hava klemperer meretzki start my free trial ➤ see more educational background bachelors degree in law  class of   the hebrew university of jerusalem the hebrew university of jerusalem is israels second oldest university established in   years before the state of israel the hebrew university has three campuses in jerusalem and one in rehovot the worlds largest jewish studies library is located on its edmond j safra givat ram campus career history partner current meretzkitavor vice chairmannational council current israel bar association boards  committees corporate boards ▾ member board of directors   current pluristem therapeutics inc pluristem therapeutics inc is a biotechnology company engages in the provision of cell therapy development it focuses on cell therapies for the treatment of diseases such as muscle injury acute radiation syndrome pulmonary arterial hypertension and others its products include placental expanded plxpad and plxr the company was founded by doron shorrer on may   and is headquartered in haifa israel director prior the israel electric corp ltd israel electric corp ltd generates transmits sells and distributes electricity it offers its services to the households industrial public and commercial buildings and bulk water pumping and agriculture the company was founded on march   and is headquartered in haifa israel director prior israel electric co nonprofit boards ▾ vice chairman national council    israel bar association public holdings restricted data only for relsci professional users start my free trial ➤ see more awards  honors professional certification  admitted to the israel bar other affiliations hava klemperer meretzki is affiliated with meretzkitavor israel bar association pluristem therapeutics inc the israel electric corp ltd israel electric co israel bar association youve reached your  free profiles limit this month upgrade to relsci pro today to enjoy unlimited article views and much more start my free trial ➤ still not convinced check out our full listing of features here are you a relsci pro subscriber login to relsci pro  ➤ not a pro subscriber log in here to manage your alerts keep me signed in login  ➤ forgot your password i have read the lexisnexis terms  conditions sign me up  ➤ hava meretzki   decypha sign in  welcome guest regions gcc  levant  mena  north africa gcc bahrain  kuwait  oman  qatar  saudi arabia  united arab emirates levant iraq  jordan  lebanon  palestine north africa egypt  libya  morocco  tunisia others iran  turkey  united kingdom  united states advanced search news markets companies research funds fixed income money markets commodities fx economics analysis more sign in membership customize your decypha logout welcome decypha alerts home people profiles people profile hava meretzki profile full name hava meretzki country biography ms meretzki became a director of the company in october  ms meretzki is an attorney and is a partner in the law firm of meretzki  tavor in haifa designations date designation entity entity description country  pluristem therapeutic   check all the individuals in check the list request a trial title select mr mrs ms miss dr prof first name last name job title select asset managers corporate banks investment managers wealth managers consultants  advisors legal practioners academics hedge funds private equity analysts traders equity research analysts phone company email country select afganistan albania algeria american samoa andorra angola anguilla antarctica antigua and barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia and herzegovina botswana bouvet island brazil british indian ocean territory brunei bulgaria burkina faso burundi cambodia cameroon canada cape verde cayman islands central african republic chad chile china christmas island cocos keeling islands colombia comoros congo cook islands costa rica cote divoire ivory coast croatia hrvatska cuba curacao cyprus czech republic czechoslovakia former denmark djibouti dominica dominican republic east timor ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland islands malvinas faroe islands fiji finland france france metropolitan french guiana french polynesia french southern territories gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guernsey guinea guineabissau guyana haiti heard and mcdonald islands honduras hong kong hungary iceland india indonesia iran iraq ireland isle of man israel italy jamaica japan jersey jordan kazakhstan kenya kiribati kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macau macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mayotte mexico micronesia moldova monaco mongolia montenegro montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles neutral zone new caledonia new zealand aotearoa nicaragua niger nigeria niue norfolk island north korea northern mariana islands norway oman pakistan palau palestine panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russia rwanda s georgia and s sandwich isls saint kitts and nevis saint lucia saint vincent and the grenadines samoa san marino sao tome and principe saudi arabia senegal serbia seychelles sierra leone singapore slovak republic slovenia solomon islands somalia south africa south korea south sudan spain sri lanka st helena st pierre and miquelon sudan suriname svalbard and jan mayen islands swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad and tobago tunisia turkey turkmenistan turks and caicos islands tuvalu us minor outlying islands ussr former uganda ukraine united arab emirates united kingdom united states uruguay uzbekistan vanuatu vatican city state holy see venezuela vietnam virgin islands british virgin islands us wallis and futuna islands western sahara yemen yugoslavia zaire zambia zimbabwe comments required fields   submit already registered login attempt was not successful please try again username email password enter characters   login forget your password by job title asset managers  corporate banks  investment managers  wealth managers  consultants  advisors  legal practitioners  academics  hedge funds  private equity analysts  traders  equity research analysts by scope equity  fixed income  funds  excel  analytical tools  markets  prices  money market  news  industry  ipos  mergers  acquisitions  commodities  economics covered countries and exchanges add your company   add yourself   terms and conditions   privacy policy   about directfn copyright  directfn all rights reserved data not available login login attempt was not successful please try again username email password enter characters forget your password back to top support  feedback ask for free trial request a trial title mr mrs ms miss dr prof first name last name email phone promo code country select afganistan albania algeria american samoa andorra angola anguilla antarctica antigua and barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia and herzegovina botswana bouvet island brazil british indian ocean territory brunei bulgaria burkina faso burundi cambodia cameroon canada cape verde cayman islands central african republic chad chile china christmas island cocos keeling islands colombia comoros congo cook islands costa rica cote divoire ivory coast croatia hrvatska cuba curacao cyprus czech republic czechoslovakia former denmark djibouti dominica dominican republic east timor ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland islands malvinas faroe islands fiji finland france france metropolitan french guiana french polynesia french southern territories gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guernsey guinea guineabissau guyana haiti heard and mcdonald islands honduras hong kong hungary iceland india indonesia iran iraq ireland isle of man israel italy jamaica japan jersey jordan kazakhstan kenya kiribati kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macau macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mayotte mexico micronesia moldova monaco mongolia montenegro montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles neutral zone new caledonia new zealand aotearoa nicaragua niger nigeria niue norfolk island north korea northern mariana islands norway oman pakistan palau palestine panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russia rwanda s georgia and s sandwich isls saint kitts and nevis saint lucia saint vincent and the grenadines samoa san marino sao tome and principe saudi arabia senegal serbia seychelles sierra leone singapore slovak republic slovenia solomon islands somalia south africa south korea south sudan spain sri lanka st helena st pierre and miquelon sudan suriname svalbard and jan mayen islands swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad and tobago tunisia turkey turkmenistan turks and caicos islands tuvalu us minor outlying islands ussr former uganda ukraine united arab emirates united kingdom united states uruguay uzbekistan vanuatu vatican city state holy see venezuela vietnam virgin islands british virgin islands us wallis and futuna islands western sahara yemen yugoslavia zaire zambia zimbabwe company job title select academics asset managers consultants  advisors corporate banks equity research analysts hedge funds investment managers legal practioners private equity analysts traders wealth managers comments required fields   submit contact us hello please use the below form for product support  feedback name   email  phone number   preferred contact method  email phone technical support x     slhopsdirectfnnet your account manager is   get a decypha membership to view this content get a decypha membership get the membership of decypha premium package to access more exciting features including advanced analytical tools and the pro  package pro  is designed keeping active investors in mind and offers a flexible framework to view information and do analysis the way you desire all you need to access these valuable features is to click on the get a membership button and submit your details to our sales team upgrade your membership account is not entitled to view this information please contact your account manager to upgrade your membership email  supportdecyphacom register to view this content decypha free registration register free with decypha and get access to realtime price information and many other features including technical scanner fundamental screener etc just click the registration button submit your details and get registered for free shai meretzki  pluristem therapeutics inc  zoominfocom psti hava klemperer meretzki insider trades for pluristem therapeutics inc x tweet share this bulletin get news bulletins by email bulletin white house briefs reporters after spicer quits as press secretary live blog » investor alert new york markets close in market snapshot winners and losers expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close pluristem therapeutics inc nasdaq psti go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus pluristem therapeutics inc market open  real time quotes jul    pm psti quoteszigmancomposite   change   volume volume  real time quotes quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual hava klemperer meretzki ms hava k meretzki is partner at meretzkitavor and vice chairmannational council at israel bar association she is on the board of directors at pluristem therapeutics inc she received her undergraduate degree from the hebrew university of jerusalem transactions date shares transaction value     award at  per share      award at  per share      award at  per share      award at  per share      award at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives mr zami aberman chairman  cochief executive officer mr yaky yanay president cochief executive officer  director mr erez egozi chief financial officer  treasurer dr esther lukasiewiczhagai vice presidentclinical  medical affairs dr racheli ofir vice presidentresearch  intellectual property dr hillit mannor shachar vice presidentbusiness development dr moria kwiat director ms hava klemperer meretzki director mr isaac braun director mr mark s germain director mr efrat kaduri managerinvestor  public relations ms karine kleinhaus vice presidentnorth america division  ir contact ms efrat livnehadass vice presidenthuman resources mr doron shorrer independent director mr israel benyoram independent director mr nachum rosman independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  pm edt july   marketstatecountryus new york open marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pgold logs highest finish in a month up over  for the week pmicrosoft is challenging amazon for cloud throne pam i entitled to a spousal benefit pwhite house briefs reporters after spicer quits as press secretary live blog pnot even free money can make some people go to the gym p seriously inappropriate things you should never ever say to a coworker pwant to buy happiness splurge on these  things pnote to parents this social network was rated the worst for teenage cyberbullying ppreserving a fruitful retirement pthis is the deadliest time of your life to put on weight pthe dark side of cruises p reasons why millennials can’t have nice things or save any money pwhat eleanor roosevelt and helen gurley brown ate — and what we can learn from it p moneymaking lessons from the richest man who ever lived p‘property brothers’ is inspiring homeowners to remodel — but creating fictional expectations about how much it costs pthis week’s retirement news phollywood is using social causes to sell movie tickets pgold marks highest settlement in a month up over  for the week pspicer says in a tweet hell continue in job through august pgold prices end at highest level in a month up over  for the week loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  pluristem therapeutics inc plrsf people  reuterscom x edition united states africa américa latina عربي argentina brasil canada  deutschland españa france india italia  méxico россия united kingdom united states pluristem therapeutics inc plrsf related topics stocksstock screenermarket datahealthcarebiotechnology  medical research overview news key developments people charts financials analysts research pulse plrsf on frankfurt stock exchange eur am edt change  chg €  prev close € open € days high € days low € volume  avg vol  wk high € wk low € summary name age since current position yaky yanay   chairman of the board chief executive officer zalman aberman   president cochief executive officer director erez egozi   chief financial officer doron shorrer   lead independent director moria kwiat   director hava meretzki   director israel benyoram   independent director issac braun   independent director mark germain   independent director nachum rosman   independent director karine kleinhaus  divisional vice president northamerica » insider trading biographies name description yaky yanay mr yaky yanay is chairman of the board chief executive officer of pluristem therapeutics inc his work experience includes the following roles president chief operating officer at the company from february   chief financial officer and secretary at the company from november  chief financial officer of elbit vision systems ltd and cochairman of israel advanced technology industries an umbrella organization representing israel’s hitech and lifescience industries he holds a bachelor of business administration degree from hamichlala leminhal he is a certified public accountant zalman aberman mr zalman zami aberman is president cochief executive officer director of pluristem therapeutics inc he changed the company’s strategy towards cellular therapeutics mr aberman’s vision to use the maternal section of the placenta decidua as a source for cell therapy combined with the company’s d culturing technology led to the development of our products since november  mr aberman has served as a director of the company and since april  as chairman of the board he has  years of experience in marketing and management in the high technology industry mr aberman has held positions of ceo and chairman positions in companies in israel the united states europe japan and korea mr aberman operated within hightech global companies in the fields of automatic optical inspection network security video over ip software chip design and robotics he serves as the chairman of rose hitech ltd a private investment company he served in the past as the chairman of vlscom ltd a private company specializing in video compression for hdtv and video over ip and as a director of ori software ltd a company involved in data management prior to that mr aberman served as the president and ceo of elbit vision system ltd evsnfob a company engaged in automatic optical inspection prior to his service with the company mr aberman served as president and ceo of netect ltd specializing in the field of internet security software and was the cofounder president and ceo of associative computing ltd which developed an associative parallel processor for realtime video processing he also served as chairman of display inspection systems inc specializing in laser based inspection machines and as president and ceo of robomatix technologies ltd erez egozi mr erez egozi has been appointed chief financial officer at pluristem therapeutics inc effective march   his work experience includes the following roles vice president  finance and secretary at the company senior director of financeworldwide finance controller at verints communications and cyber intelligence solutions division has held several financial positions at intel corporation  and auditor in the hitech technology sector at deloitte  touche  doron shorrer mr doron shorrer cpa is lead independent director of pluristem therapeutics inc mr shorrer was one of the company’s founders and served as its first chairman until  mr shorrer also serves as a director of other companies provident fund for employees of the israel electric company ltd and for hebrew university employees and massad bank from the international bank group between  and  he was chairman of the boards of phoenix insurance company one of the largest insurance companies in israel and of mivtachim pension funds group the largest pension fund in israel prior to serving in these positions mr shorrer held senior positions that included arbitrator at the claims resolution tribunal for dormant accounts in switzerland economic and financial advisor commissioner of insurance and capital markets for the state of israel member of the board of directors of “nechasim” of the state of israel member committee for the examination of structural changes in the capital market the brodet committee general director of the ministry of transport founder and managing partner of an accounting firm with offices in jerusalem telaviv and haifa member of the lecture staff of the hebrew university business administration school chairman of amal school chain chairman of a public committee for telecommunications and economic consultant to the ministry of energy among many areas of expertise mr shorrer holds a ba in economics and accounting and an ma in business administration specialization in finance and banking from the hebrew university of jerusalem and is a certified public accountant in israel moria kwiat dr moria kwiat serves as director of pluristem therapeutics inc dr kwiat holds a bsc and an msc in biotechnology from tel aviv university and a phd from the tel aviv university center for nanoscience and nanotechnology dr kwiat served as a teaching assistant at tel aviv university from  through  currently dr kwiat is a postdoc fellow at the faculty of chemistry of tel aviv university working on the development of new generation of biosensors based on nanomaterials hava meretzki ms hava meretzki is director of pluristem therapeutics inc ms meretzki is an attorney and is a partner in meretzki law firm in haifa israel ms meretzki specializes in civil trade and labor law and is presently the chairman of the national council of the israel bar association ms meretzki received a bachelors degree in law from the hebrew university in  and was admitted to the israel bar association in  we believe that ms meretzki’s qualifications to sit on our board include her years of experience with legal and corporate governance matters israel benyoram mr israel benyoram is independent director of pluristem therapeutics inc he has been a director and partner in the accounting firm of mor benyoram and partners in israel since  in addition since  mr benyoram has been a shareholder and has served as the head director of mor benyoram ltd a private company in israel in parallel to the operation of mor benyoram and partners this company provides management services economic consulting services and other professional services to businesses furthermore mr benyoram is the ceo of eshed dash ltd and zonbit ltd during  mr benyoram served as a director of brainstorm cell therapeutics inc bcli and smart energy solutions inc smgy both of which were traded on the nasdaq issac braun mr issac braun is independent director of pluristem therapeutics inc mr braun is a business veteran with entrepreneurial industrial and manufacturing experience he is a cofounder and has been a board member of several hitech startups in the areas of ecommerce security messaging search engines and biotechnology mr braun is involved with advising private companies on raising capital and business development mark germain mr mark s germain is independent director of pluristem therapeutics inc between may  and february  mr germain served as cochairman of our board for more than five years mr germain has been a merchant banker serving primarily the biotech and life sciences industries he has been involved as a founder director chairman of the board of andor investor in over twenty companies in the biotech field and assisted many of them in arranging corporate partnerships acquiring technology entering into mergers and acquisitions and executing financings and going public transactions he graduated from new york university school of law in  order of the coif and was a partner in a new york law firm practicing corporate and securities law before leaving in  since then and until he entered the biotech field in  he served in senior executive capacities including as president of a public company which was sold in  in addition to being a director of the company mr germain is a director of chromadex inc cdxbob a publicly traded company mr germain also serves as a director of the following companies that were reporting companies in the past stem cell innovations inc omnimmune corp and collexis holdings inc he is also a cofounder and director of a number of private companies in and outside the biotechnology field nachum rosman mr nachum rosman is independent director of pluristem therapeutics inc he provides management and consulting services to startup companies in the financial organizational and human resource aspects of their operations mr rosman also serves as a director at several privately held companies throughout his career mr rosman held ceo and cfo positions in israel the united states and england in these positions he was responsible among other things for finance management fund raising acquisitions and technology sales mr rosman holds a bsc in management engineering and an msc in operations research from the technion haifa israel mr rosman also participated in a phd program in investments and financing at the tel aviv university israel karine kleinhaus ms karine kleinhaus md is divisional vice president north america of pluristem therapeutics inc she has worked with multiple public and private biotechnology companies on both public and investor relations prior to that she was an assistant professor in the departments of obstetrics and gynecology and psychiatry at the nyu school of medicine at nyu dr kleinhaus conducted medical research funded under a multiyear nih grant she published more than  papers in leading peerreviewed journals such as the annals of the new york academy of science american journal of medical genetics and the american journal of epidemiology before that dr kleinhaus practiced obstetrics and then completed two fellowships at columbia university dr kleinhaus received her medical degree from tel aviv university earned a master of public health from columbia’s mailman school of public health and a bachelor’s degree cum laude from princeton university basic compensation name fiscal year total yaky yanay  zalman aberman  erez egozi  doron shorrer  moria kwiat  hava meretzki  israel benyoram  issac braun  mark germain  nachum rosman  karine kleinhaus  as of   jun  options compensation name options value yaky yanay   zalman aberman   erez egozi   doron shorrer   moria kwiat   hava meretzki   israel benyoram   issac braun   mark germain   nachum rosman   karine kleinhaus   insider trading name shares traded price egozi erez   aberman zalman   yanay yaky   rosman nachum   meretzki klemperer hava   aberman zalman   kwiat moria   germain mark s   benyoram israel   braun isaac   yanay yaky   shorrer doron   shorrer doron   aberman zalman   yanay yaky   aberman zalman   aberman zalman   yanay yaky   yanay yaky   yanay yaky   benyoram israel   aberman zalman   benyoram israel   meretzki klemperer hava   yanay yaky   » full list on insider trading related topics stocksstock screenermarket datahealthcarebiotechnology  medical research reuterscom x edition united states africa américa latina عربي argentina brasil canada  deutschland españa france india italia  méxico россия united kingdom united states people pluristem therapeutics inc pstio related topics stocksstock screenerhealthcarebiotechnology  medical research overview news key developments people charts financials analysts research pulse pstio on consolidated issue listed on nasdaq capital market usd  jul  change  chg   prev close  open  days high  days low  volume  avg vol  wk high  wk low  meretzki hava  ms hava meretzki is director of pluristem therapeutics inc ms meretzki is an attorney and is a partner in meretzki law firm in haifa israel ms meretzki specializes in civil trade and labor law and is presently the chairman of the national council of the israel bar association ms meretzki received a bachelors degree in law from the hebrew university in  and was admitted to the israel bar association in  we believe that ms meretzki’s qualifications to sit on our board include her years of experience with legal and corporate governance matters basic compensation total annual compensation  restricted stock awards  longterm incentive plans  all other  fiscal year total  options compensation   quantity market value exercisable   unexercisable   exercised   basic compensation name fiscal year total yaky yanay  zalman aberman  erez egozi  doron shorrer  moria kwiat  hava meretzki  as of   jun  » view all officers related topics stocksstock screenerhealthcarebiotechnology  medical research pluristem therapeutics inc company  shareholders managers and business summary  nasdaq psti  traders log in email password remember forgot password  become a member for free sign up sign up new membersign up for free new customerdiscover our portfolios united states united kingdom france deutschland schweiz de suisse fr settings dynamic quotes  offon markets equities north americaeuropeasiaoceaniamiddle east� more equities indexes dow jonessp nasdaq tsx compftse � more indexes currency  forex eur  usdgbp  usdusd  jpyusd  cadaud  usd� more currencies commodities goldcrude oil wticrude oil brentsilverplatinum� more commodities news latest news companiesmarketseconomycurrency  forexcommoditiesinterest ratesbusiness leadersfinancial calendareconomic calendar listed company analyst recorumorsiposcapital markets transactionsnew contractsprofits warningsappointmentspress releaseseventscorporate actions sector news energybasic materialsindustrialsconsumer cyclicalconsumer noncyclicalfinancialshealthcaretechnologytelecommunications servicesutilities analysis all analysiscommentariesindex analysisstock trading strategiescommodity analysisforex analysis stock picks all stock picks portfolios my portfolio virtual portfolios traders portfolios european portfoliousa portfolioasian portfolio screeners market screener homefundamental analyse top investor ratingtop trading ratingtop consensusgrowth stocksyield stockslow valuations technical analysis oversold stocksoverbought stocksclose to resistancesclose to supportsaccumulation phasemost volatile stocks watchlists my watchlists watchlists top lists yield stocksgrowth stocksundervalued stocks top  flop top news most read newshot news top fundamentals top capitalizationtop yieldtop pertop consensustop fundamentals top technicals top rsiunusual volumestop gapstop stim top movers top usatop canadatop uktop germanytop europetop asia tools market screenerdynamic chartfinancial calendareconomic calendarsector researchcurrency converter our services premium accessdiscover our services traders homepage    equities    nasdaq    pluristem therapeutics inc    psti download report pluristem therapeutics inc psti add to my list    mes derni�res consultmost popular manage my lists  delayed     pm  usd     pluristem advances its multinational phase iii critical limb isch  pluristem to present new data from ars study at radiology confere  pluristem thera  psti files an k departure of directors or certa summaryquoteschartsnewscalendarcompanyfinancialsconsensusrevisions  business summary develops stem cell production technologypluristem therapeutics inc is a biotechnology company engages in the provision of cell therapy developmentit focuses on cell therapies for the treatment of diseases such as muscle injury acute radiation syndrome pulmonary arterial hypertension and othersits products include placental expanded plxpad and plxrthe company was founded by doron shorrer on may   and is headquartered in haifa israel number of employees   persons sales per businesses deltausd in millionusd in millioncell therapeutics and related technologies  sales per regions deltausd in millionusd in millionglobal  managers nameagesincetitlezami abermanchairman  cochief executive officeryaky yanaypresident cochief executive officer  directorsagi moranvice presidentoperationserez egozichief financial officer  treasureresther lukasiewiczhagai md phdvice presidentclinical  medical affairsmark s germaindirectornachum rosmanindependent directorisrael benyoram mbaindependent directorisaac braundirectorhava klemperer meretzkidirector equities vote quantityfloatcompanyowned sharestotal float share a        shareholders nameequitieszami aberman  yaky yanay  renaissance technologies llc  menora mivtachim insurance ltd  doron shorrer mba  migdal mutual funds ltd  israel benyoram mba  mark s germain  hava klemperer meretzki  isaac braun   sector healthcarepharmaceuticals  medical research biotechnology  medical research  biotechnology  medical research   biotechnology  medical research  nec sector biotechnology  medical research  nec st jancapitalization m pluristem therapeutics inc incyte corporation  quintiles ims holdings inc  lonza group  celltrion inc  alkermes plc  qiagen nv  seattle genetics inc  alnylam pharmaceuticals inc  ionis pharmaceuticals inc  united therapeutics corporation  icon plc  charles river laboratories intl inc  pra health sciences inc  exact sciences corporation  parexel international corporation  biotechne corp  galapagos  portola pharmaceuticals inc  acadia pharmaceuticals inc  puma biotechnology inc  sector biotechnology  medical research  nec connections  pluristem therapeutics inc elbit vision systems ltd yaky yanay rose hitech ltd zami aberman israel advanced technology industries yaky yanay mor benyoram ltd israel benyoram eyecue vision technologies ltd yaky yanay alliance for regenerative medicine zami aberman talecity ltd nachum rosman meretzkitavor hava klemperer meretzki eshed dash ltd israel benyoram simba ltd nachum rosman omnimmune corp mark s germain zoomix data mastering ltd nachum rosman amphioxus cell technologies inc mark s germain zonbit ltd israel benyoram the olmsted group mark s germain society of trust  estate practitioners ltd israel benyoram multiview ltd nachum rosman israel bar association hava klemperer meretzki company contact information pluristem therapeutics incmatam advanced technology parkbuilding no haifa phone  fax  web  wwwpluristemcom   people  fundamentals and ownership    traderscom marketsnewsanalysisstock picksportfoliosscreenerswatchliststop  floptoolsour servicesabout surperformance sascontact usadvertiselegal informationsabout usstay connected facebooktwitterpartners b�rse aktien kurse und nachrichtenbest tweets copyright �  surperformance all rights reserved slave pluristem expands board of directors appoints seasoned professionals to provide strategic direction in meeting aggressive growth objectives  business wire pluristem expands board of directors appoints seasoned professionals to provide strategic direction in meeting aggressive growth objectives october    am eastern daylight time haifa israelbusiness wireoct  pluristem life sciences inc otc bbplrs a biotechnology company dedicated to the expansion of stem cells to address a myriad of fatal illnesses today announced that the company has expanded its board of directors through the appointment of doron shorrer cpa isr as chairman hava klemperer meretzki and robert j pico to assist in providing strategic direction in meeting aggressive growth objectives doron shorrer isr cpa was chairman of the board of phoenix insurance company one of the largest insurance companies in israel and mivtachim pension benefit group the largest pension fund in israel managing  billion before assuming these positions shorrer held senior appointments that included arbitrator at the claims resolution tribunal for dormant accounts in switzerland economic and financial advisor commissioner of insurance and capital markets for the state of israel member of the board of directors of nechasim of the state of israel member of the committee for the examination of structural changes in the capital market the brodet committee general director of the ministry of transport cofounder and director of an accounting firm having three branches jerusalem telaviv haifamember of the lecture staff of the amal school chain chairman of a public committee for telecommunications and economic consultant to the ministry of energy among many areas of expertise mr shorrer formulates implements and administers business planning in the private and institutional sector he additionally consults on economic accounting and taxation issues to a large audience ranging from private concerns to government ministries mr shorrer holds a ba in economics and accounting and an ma in business administration specialization in finance and banking from the hebrew university of jerusalem he is a certified public accountant isr hava klemperer meretzki adv is a partner in the law firm of bennoun meretzki in haifa israel she specializes in civil trade and labor law and is presently vicechairman for the national council of the israel bar association she previously was a director of the israel electric company meretzki received a bachelors degree in law from the hebrew university in  and in  was admitted to the israel bar association robert j pico is presently vice president of business development at transwitch corporation nasdaqtxcc he leads all ma activities and initialization of startup companies through seed funding for companies that include teraop optix icc onex acquired by txcc sosi acquired by txcc mr pico additionally invests on behalf of transwitch in companies that demonstrate significant growth opportunities including accordian networks he performs all contract negotiations for transwitch when acquiring third party intellectual property such as vlsi cell libraries and semiconductor foundry service contracts from suppliers such as texas instruments nysetxn tsmc in taiwan and lsi logic nyselsi mr pico has led the transwitch team consummating more than  acquisitions and formation of startup companies spanning israel north america europe and asia he is a board member of several of these companies pico joined transwitch in  and assisted in its public offering in  on the nasdaq exchange mr pico has a breadth of corporate management expertise spanning engineering operations and business development prior to his tenure at transwitch he held senior positions in both large multinational corporations such as itt and united technologies he holds a bsee and ms in physics from the university of hartford and trinity college respectively and has completed his requirements for an mba in marketing from the university of hartford irit arbel ceo commented we are most pleased that doron shorrer hava meretzki and robert pico have accepted appointments to the board of directors their backgrounds in law accounting mergers and acquisitions startup entities and advising corporations and governments we believe will be of great assistance to pluristem as the company continues to meet milestones and plans for future activities such as strategic alliances joint ventures and the many opportunities that lie ahead about pluristem pluristem is a biotechnology company dedicated to the development of stem cell expansion technology the company is concentrating on the expansion of cord blood hematopoietic stem cells and may provide upon successful development and regulatory approval critical cell expansion services to blood banks and transplants centers in the us and europe safe harbor statement statements in this document that are not purely historical are forwardlooking statements forwardlooking statements in this release include statements regarding our developing stem cell technology into a useful product that could address fatal illnessesand that our new board members will help us meet our milestones and plans actual outcomes and our actual results could differ materially from those in such forwardlooking statements factors that could cause actual results to differ materially include risks and uncertainties such as the inability to complete its obligations under the stem cell license agreement inability to finance the planned development of the technology inability to obtain regulatory approval for commercial use of our products and unforeseen technical difficulties in developing the stem cell technology and inability to keep our directors and management which could among other things delay or prevent product release for further risk factors see our k filed with the sec june   contacts demonte associates new yorkcynthia demonte cdemontedemontecom contacts demonte associates new yorkcynthia demonte cdemontedemontecom search advanced news search advanced news search log in sign up the company  pluristem therapeutics inc pluristem therapeutics inc pluristem therapeutics inc company products plx products pipeline – plxpad critical limb ischemia intermittent claudication orthopedic indications pulmonary arterial hypertension women’s health pipeline – plxr hematology acute radiation syndrome clinical programs clinical development strategy critical limb ischemia cli intermittent claudication ic muscle injury acute radiation syndrome ars hematopoietic cell transplantation pulmonary arterial hypertension pah science  technology mechanism of action d manufacturing platform placenta intellectual property additional technologies preclinical programs scientific publications collaborations partnering strategy industry partners academic partners investors  media news from the media events presentations financial statements sec filing covering analysts corporate governance ir team pluristem therapeutics inc is a clinicalstage biotherapy company using placental cells and a unique proprietary threedimensional d technology platform to develop cell therapies for conditions such as inflammation ischemia hematological disorders or exposure to radiation our vision our vision is to leverage our advanced technology and our position as a global leader in cell therapy to develop and manufacture highly effective cell products that will heal patients around the world our strategy our strategy is to develop powerful cell therapies that can be successfully commercialized to reach patients who need innovative treatment options we develop placentaderived “offtheshelf” products that do not need genetic or tissue matching prior to administration and could be delivered in almost any clinical setting we design distinct cell products to target a variety of indications and anticipate that a pipeline of differentiated products and indications will allow us to target large global markets we explore new partnerships to advance our clinical development programs while maintaining our strong commitment to current corporate academic and government collaborations management team zami aberman chairman  coceo zami aberman joined pluristem in september  and redirected the companys strategy towards cellular therapeutics to become one of the global leaders in the industry mr abermans vision to use the maternal portion of the placenta as a cell source for pluristem’s products combined with pluristems d culturing technology led to the development of the companys unique therapies in  the world stem cells regenerative medicine congress ranked mr aberman as one of the  most influential people in the stem cells space prior to pluristem mr aberman had a  year career as a senior executive in the hightech industry with multiple companies in israel the us europe japan and korea previous roles include chairman of vlscom ltd a private company specializing in video compression for hdtv and video over ip director of ori software ltd a company involved in data management president and ceo of elbit vision systems evsnfob which supplies inspection systems for the microelectronics industry president and ceo of netect ltd a company specializing in the field of internet security software cofounder president and ceo of associative computing ltd which developed an associative parallel processor for realtime video processing chairman of display inspection systems inc a company specializing in laser based inspection machines and president and ceo of robomatix technologies ltd rbmxfob in addition to his current role at pluristem mr aberman serves as the chairman of rose hitech ltd a private investment company in  mr aberman was awarded the rothschild prize for excellence in his field from the president of the state of israel mr aberman holds a bsc in mechanical engineering from ben gurion university in israel yaky yanay coceo and president yaky yanay was appointed as our president from february  and as our coceo from march  mr yanay served as our chief financial officer from november  until february  and from february  until march  he also served as our chief operating officer from february  until march  until february  he also served as our secretary since november  and executive vice president since march  before joining pluristem mr yanay was the chief financial officer of elbit vision systems ltd a public company prior to that mr yanay served as manager of audit groups of the technology sector at ernst  young israel mr yanay is cochairman of israel advanced technology industries iati the largest umbrella organization representing israel’s high tech and life science industries yanay is representing israel’s life sciences industry and has served on the board of directors of iati for the past four years mr yanay also founded and served as chairman of the “the life science forum” mr yanay holds a bachelor’s degree with honors in business administration and accounting and is a certified public accountant in israel efrat livnehadass vp human resources efrat livnehadass joined pluristem in  and is responsible for all aspects of human resources management including recruitment professional training and wellbeing prior to joining pluristem and during the years  ms livnehadass held the position of human resources manager at elbit vision systems a company engaged in automatic optical inspection located in yokneam israel while holding that position she was involved in some major challenges and change processes which the company was going through including managing hr in a small yet global public company ms livnehadass holds an executive ma for human resources managers from the department of labor studies telaviv university and a bsw degree from the haifa university majoring in public healthcare services hillit mannor shachar md vp business development hillit mannor shachar md joined pluristem in october  as vp of business development prior to joining pluristem dr shachar had over ten years experience in both business development and corporate development having worked and consulted at companies including west pharmaceutical services nektar therapeutics orex computer radiography acquired by kodak and transpharma medical dr shachar worked at apax partners as a healthcare associate and at deloitte israel as a consultant in their life science practice dr shachar graduated from northwestern universitys honors program in medical education and holds a ba and md from there in addition she holds a mba from kellogg recanati executive program and an msfs from georgetown university erez egozi cfo mr erez egozi was appointed chief financial officer in march  and as secretary in september  prior to his appointment as cfo mr egozi was our vice president of finance from march  until march  before joining pluristem from  to  mr egozi held several senior financial positions at verint systems inc nasdaqvrnt including as senior director of finance  worldwide finance controller of verints communications and cyber intelligence solutions division from  to  mr egozi held several financial positions at intel corporation nasdaqintc from  to  mr egozi served as an auditor in the high tech technology sector at deloitte  touche  mr egozi holds a bachelors degree in economics and accounting from beersheva university and a ma degree in law from barilan university and is a certified public accountant in israel esther lukasiewicz hagai md phd vp clinical  medical affairs dr lukasiewiczhagai has twelve years experience in drug development she joins pluristem from teva global rd where she was director clinical program leader leading the global clinical development of multiple biosimilars and innovative drugs in various oncologic and neuropsychiatric indications she previously worked at gertner institute for epidemiology and health policy research sheba medical center tel hashomer where she was responsible of multiple national and usisraeli clinical trials in orthopedic and hematooncologic indications dr lukasiewiczhagai holds a md and a medical residency in public health and social medicine from neckerenfants malades paris v school of medicine in addition she holds a master of methodology and statistics in clinical research and a m med sc in biostatistics and epidemiology from paris xi as well as a phd in biostatistics from barilan university sagi moran mba vp operations sagi moran joined pluristem in june  as vp of operations prior to joining pluristem mr moran served as the cto for laser medical device startup axonogen ltd and as coo for novoxel ltd mr moran established a medical division for qualitest group ltd the largest engineering and testing services group for the medical industry in israel the division provides services for pharmaceutical and medical companies such as teva philips healthcare ge ultrashape given imaging and others prior to that mr moran served for  years in lumenis ltd in key global managerial position in rd and operations mr moran holds a master of business administration mba from recanati executive mba program at telaviv university and a bachelor’s degree in information systems from haifa university orly amiran vp quality assurance orly amiran holds a master degree in quality assurance from the technion and a bsc in pharmacy from the hebrew university she has worked in the pharmaceutical industry since  and has extensive experience in quality assurance management in global companies which market drugs to the european market and to north america prior to joining pluristem orly held the positions of quality assurance manager at teva and compliance manager at taro she played a central role in successful regulatory agencies inspections in both positions ms orly amiran brings with her to pluristem a vast experience and knowledge on gmp quality regulations and the corresponding industry best practices racheli ofir phd ma law vp research  intellectual property racheli ofir joined pluristem in  serves as vice president of research and intellectual property the research department examines the various cells developed by the company the properties of those cells and their mechanisms of action by using molecular methods and animal models to test the safety and efficacy the ip department is responsible for intellectual property strategy development as well as the research that supports the ip dr ofir is responsible for leading projects involving the characterization of plx cells pluristems leading placenta derived cell product candidate including evaluating the biological activity of the cells in invitro and animal studies she is responsible for the studies which determines the safety profile and pharmacokinetics of plx cells in addition she is in charge of all preclinical aspects of the plx regulatory process and for the communications with the relevant regulatory authorities fda ema and pei dr ofir is also responsible for applying and prosecuting over ten patent families filed worldwide a coinventor on five patent applications and the coauthor of numerous peer reviewed articles dr ofir earned her phd from the technion israel institute of technology where she investigated telomeric position effects on gene expression and dna replication in human cells she did her postdoctoral fellowship at the technion in molecular embryology investigating genes involved in early development of vertebrates nervous system dr ofir has extensive research experience in molecular cell biology embryology and cytogenetics as well as broad professional experience in the field of human cell therapy lior raviv vp development lior raviv joined pluristem in  and currently serves as vice president of development prior to that mr raviv served as process development engineer and projects manager  product development team leader at pluristem prior to joining pluristem and during the years  mr raviv held the position of rd analytical researcher at teva pharmaceutical industries mr raviv holds a mmedsec in pharmacology from the ben gurion university and a bsc in biotechnology engineering from the ben gurion university karine kleinhaus md mph divisional vp north america karine kleinhaus md mph is divisional vice president north america at pluristem therapeutics she has worked with multiple public and private biotechnology companies and prior to that she was an assistant professor in the departments of obstetrics and gynecology and psychiatry at the nyu school of medicine at nyu dr kleinhaus conducted medical research funded under a multiyear nih grant she published more than  papers in leading peerreviewed journals such as the annals of the new york academy of science american journal of medical genetics and the american journal of epidemiology before that dr kleinhaus practiced obstetrics and then completed two fellowships at columbia university dr kleinhaus received her medical degree from tel aviv university earned a master of public health from columbia’s mailman school of public health and a bachelor’s degree cum laude from princeton university board zami aberman mr zami aberman joined pluristem in september  and redirected the companys strategy towards cellular therapeutics to become one of the global leaders in the industry mr abermans vision to use the maternal portion of the placenta as a cell source for pluristem’s products combined with pluristems d culturing technology led to the development of the companys unique therapies in  the world stem cells regenerative medicine congress ranked mr aberman as one of the  most influential people in the stem cells space prior to pluristem mr aberman had a  year career as a senior executive in the hightech industry with multiple companies in israel the us europe japan and korea previous roles include chairman of vlscom ltd a private company specializing in video compression for hdtv and video over ip director of ori software ltd a company involved in data management president and ceo of elbit vision systems evsnfob which supplies inspection systems for the microelectronics industry president and ceo of netect ltd a company specializing in the field of internet security software cofounder president and ceo of associative computing ltd which developed an associative parallel processor for realtime video processing chairman of display inspection systems inc a company specializing in laser based inspection machines and president and ceo of robomatix technologies ltd rbmxfob in addition to his current role at pluristem mr aberman serves as the chairman of rose hitech ltd a private investment company in  mr aberman was awarded the rothschild prize for excellence in his field from the president of the state of israel mr aberman holds a bsc in mechanical engineering from ben gurion university in israel yaky yanay mr yaky yanay was appointed as pluristem’s president in february  and as coceo from march  mr yanay served as our chief financial officer from november  until february  and from february  until march  he also served as our chief operating officer from february  until march  until february  he also served as our secretary since november  and executive vice president since march  before joining pluristem mr yanay was the chief financial officer of elbit vision systems ltd a public company prior to that mr yanay served as manager of audit groups of the technology sector at ernst  young israel mr yanay is cochairman of israel advanced technology industries iati the largest umbrella organization representing israel’s high tech and life science industries yanay is representing israel’s life sciences industry and has served on the board of directors of iati for the past four years mr yanay also founded and served as chairman of the “the life science forum” mr yanay holds a bachelor’s degree with honors in business administration and accounting and is a certified public accountant in israel mark germain mr mark germain has served as a director on the board of directors since may   for more than the past five years mr germain has been a merchant banker serving primarily the biotech and life sciences industries he has been involved as a founder director chairman of the board andor investor in over twenty companies in the biotech field and assisted many of them in arranging corporate partnerships acquiring technology entering into mergers and acquisitions and executing financings and going public transactions he graduated new york university school of law in  order of the coif and was a partner in a new york law firm practicing corporate and securities law from  to  he served in senior executive capacities including as president of a public company that was sold in  at which time he entered the biotech field in addition to being cochairman at pluristem mr germain is a director of the following publicly traded companies wellford real properties inc stem cell innovations inc and collexis holdings inc he is also a cofounder and director of a number of private companies in the biotechnology field hava klemperer meretzki mrs hava klemperer meretzki adv is a partner in the law firm of bennoun meretzki in haifa israel she specializes in civil trade and labor law and is presently vicechairman for the national council of the israel bar association she previously was a director of the israel electric company ms meretzki received a bachelors degree in law from the hebrew university in  and in  was admitted to the israel bar association doron shorrer mr doron shorrer cpa israel was chairman of the board of phoenix insurance company one of the largest insurance companies in israel and mivtachim pension benefit group the largest pension fund in israel managing  billion before assuming these positions mr shorrer held senior appointments that included arbitrator at the claims resolution tribunal for dormant accounts in switzerland economic and financial advisor commissioner of insurance and capital markets for the state of israel member of the board of directors of nechasim of the state of israel member of the committee for the examination of structural changes in the capital market the brodet committee general director of the ministry of transport cofounder and director of an accounting firm having three branches jerusalem telaviv haifa member of the lecture staff of the amal school chain chairman of a public committee for telecommunications and economic consultant to the ministry of energy among many areas of expertise mr shorrer formulates implements and administers business planning in the private and institutional sector additionally mr shorrer consults on economic accounting and taxation issues to a large audience ranging from private concerns to government ministries mr shorrer holds a ba in economics and accounting and an ma in business administration with a specialization in finance and banking from the hebrew university of jerusalem he is a certified public accountant isr isaac braun mr isaac braun was appointed a director of pluristem on july   mr braun is a business veteran with entrepreneurial industrial and manufacturing experience he has been a cofounder and board member of several hitech startups in the areas of ecommerce security messaging search engines and biotechnology mr braun advises private companies on raising financing and business development israel ben yoram mr israel benyoram was appointed a director of pluristem on january   mr benyoram has been a director and partner in the accounting firm of mor benyoram and partners in israel from  to the present this accounting firm currently employs over  employees in the field of auditing consulting and associated projects since  mr benyoram has served as a shareholder and the head director of mor benyoram ltd a private company in israel in parallel with the operation of the mor benyoram and partners accounting firm this company provides management services economic consulting services and other professional services to businesses mr benyoram received a ba in accounting from the university of tel aviv an ma in economics from the hebrew university of jerusalem an llb and an mba from tel aviv university and an llm from barilan university nachum rosman mr nachum rosman is an expert in finance management and organization he has held chief executive and cfo positions in israel usa and england he has operated in hightech global companies in software and business in these jobs he was responsible for finance management fundraising acquisitions technology sales preparation of financial reports for due diligences etc mr rosman serves as a consultant to startup companies in financing strategy and reorganization he serves as the ceo of multiview ltd a company he cofounded in  he serves as a director at zoomix data mastering and knolan mr rosman was a director actively involved in the sale of new dimension ltd to bmc inc for   million prior to that he held a coceo position in rts ltd virinet ltd where he participated in the ipo on nasdaq moria kwiat dr moria kwiat is a research fellow in the department of materials and nanosciences faculty of chemistry at tel aviv university during her studies she has gained a broad scientific experience in interdisciplinary fields and currently she is working on the development of a new generation of biosensors based on nanomaterials mrs kwiat holds a bsc and msc in biotechnology from the department of molecular microbiology and biotechnology at tel aviv university and a phd in nanobiotechnology from the faculty of exact sciences at tel aviv university psti insider trading  pluristem therapeutics inc  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  pluristem therapeutics inc psti select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in common stock purchase or sale transactiondate reporteddate company symbol insiderrelationship sharestraded averageprice totalamount sharesowned filing sale  pm pluristem therapeutics inc psti shorrer dorondirector    indirect view purchase  am pluristem therapeutics inc psti aberman zamiceo  chairmandirector    directindirect view purchase  pm pluristem therapeutics inc psti yanay yakycfo coo  presidentdirector    directindirect view purchase  pm pluristem therapeutics inc psti aberman zamiceo  chairmandirector    directindirect view purchase  pm pluristem therapeutics inc psti yanay yakycfo coo  presidentdirector    directindirect view purchase  pm pluristem therapeutics inc psti shorrer dorondirector    indirect view purchase  pm pluristem therapeutics inc psti benyoram israeldirector    indirectdirect view purchase  pm pluristem therapeutics inc psti yanay yakycfo coo  presidentdirector    directindirect view purchase  pm pluristem therapeutics inc psti aberman zamiceo  chairmandirector    directindirect view purchase  am pluristem therapeutics inc psti aberman zamiceo  chairmandirector    directindirect view purchase  am pluristem therapeutics inc psti yanay yakycfo coo  presidentdirector    directindirect view purchase  pm pluristem therapeutics inc psti benyoram israeldirector    indirectdirect view sale  pm pluristem therapeutics inc psti benyoram israeldirector    indirectdirect view purchase  pm pluristem therapeutics inc psti yanay yakycfo coo  presidentdirector    directindirect view purchase  pm pluristem therapeutics inc psti aberman zamiceo  chairmandirector    directindirect view purchase  am pluristem therapeutics inc psti yanay yakycoo cfo  presidentdirector    directindirect view purchase  pm pluristem therapeutics inc psti aberman zamiceo  chairmandirector    directindirect view stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing option award  pm nana pluristem therapeutics inc psti aberman zamiceo  chairmandirector   direct view option award  pm nana pluristem therapeutics inc psti yanay yakycfo coo  presidentdirector   direct view option award  pm nana pluristem therapeutics inc psti rosman nachumdirector   indirect view option award  pm nana pluristem therapeutics inc psti kwiat moriadirector   direct view option award  pm nana pluristem therapeutics inc psti germain markdirector   direct view option award  pm nana pluristem therapeutics inc psti braun isaacdirector   direct view option award  pm nana pluristem therapeutics inc psti benyoram israeldirector   indirect view option award  pm nana pluristem therapeutics inc psti meretzki havadirector   direct view option award  pm nana pluristem therapeutics inc psti shorrer dorondirector   indirect view option award  pm nana pluristem therapeutics inc psti benyoram israeldirector   indirect view option award  pm nana pluristem therapeutics inc psti aberman zamiceo  chairmandirector   direct view option award  pm nana pluristem therapeutics inc psti yanay yakycfo coo  presidentdirector   direct view option award  pm nana pluristem therapeutics inc psti rosman nachumdirector   indirect view option award  pm nana pluristem therapeutics inc psti kwiat moriadirector   direct view option award  pm nana pluristem therapeutics inc psti germain markdirector   direct view option award  pm nana pluristem therapeutics inc psti braun isaacdirector   direct view option award  pm nana pluristem therapeutics inc psti meretzki havadirector   direct view option award  pm nana pluristem therapeutics inc psti shorrer dorondirector   indirect view option award  pm nana pluristem therapeutics inc psti yanay yakypresident coo cfo   direct view option award  pm nana pluristem therapeutics inc psti aberman zamiceo  chairmandirector   direct view   secformcom all rights reserved archives        fri  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement